Dr Charles Chiu UCSF

 

UCSF Lyme Clinical Trials Center – Information for Patients and Families 

Thank you for your interest in learning more about the Lyme Clinical Trials Network and the new University of California San Francisco (UCSF) Lyme Clinical Trials Center. UCSF will join the Lyme Clinical Trials Network led by Columbia University, which includes Children’s National Hospital (part of the National Institutes of Health), and Johns Hopkins University. This effort is funded by the Steven & Alexandra Cohen Foundation.

We know there are many people suffering from chronic/persistent Lyme and that you deserve answers, accurate diagnostics, and effective therapeutics. Bay Area Lyme has worked tirelessly on behalf of the Lyme community for over 10 years addressing precisely these issues.

Like you, we are excited about the UCSF Lyme Clinical Trials Center, and this page will be updated when there is more news to share. Please be advised of the following:

  • Bay Area Lyme is a founder and supporter of the UCSF Lyme Clinical Trials Center and has no ability to affect decisions regarding clinicians, operations, or patient access to the program.
  • Human clinical trials require qualification for participation, therefore individual patient participation is not guaranteed.
  • UCSF Lyme Clinical Trials Center is currently unable to treat Lyme patients.
  • UCSF hopes to have a clinic for patients sometime in 2024 (tbc).
  • Qualification criteria for the Lyme Clinical Trials Network have yet to be determined and may vary by trial.
  • Bay Area Lyme is only tangentially connected to the other clinics in the network.

We are collecting information from patients who are interested in being part of a Lyme disease clinical trial. If you wish to add your name to the Clinical Trials database, complete the form below.

Bay Area Lyme Foundation is unable to take calls or answer questions about this program. Thank you so much for understanding.

Name(Required)
Email(Required)

You will be contacted when a trial is starting.